| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |